References
- Scully RE, Galdabini JJ, McNeely BU. Case records of the Massachusetts General Hospital. Weekly clinicopathological expertises. N Engl J Med 1980;307:985–995.
- Hind CR, Tennent GA, Evans DJ, Pepys MB. Demonstration of amyloid A (AA) protein and amyloid P component (AP) in deposits of systemic amyloidosis associated with renal adenocarcinoma. J Pathol 1983;139:159–166.
- Vanatta PR, Silva FG, Taylor WE, Costa JC. Renal cell carcinoma and systemic amyloidosis: demonstration of AA protein and review of the literature. Hum Pathol 1983;14:195–201.
- Hiasa Y, Konishi N, Kitahori Y, Yuasa T, Fujita T, Hirao Y, Okajima E, et al. Secondary systemic amyloidosis with Hodgkin’s disease. Acta Pathol Jpn 1983;33:1069–1077.
- Somer TP, Törnroth TS. Renal adenocarcinoma and systemic amyloidosis. Immunohistochemical and histochemical studies. Arch Pathol Lab Med 1985;109:571–574.
- Lloreta J, Vadell C, Fabregat X, Serrano S. Fibrolamellar hepatic tumor with neurosecretory features and systemic deposition of AA amyloid. Ultrastruct Pathol 1994;18:287–292.
- Agha I, Mahoney R, Beardslee M, Liapis H, Cowart RG, Juknevicius I. Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor. Am J Kidney Dis 2002;40:411–415.
- Altiparmak MR, Pamuk GE, Pamuk ON. Adrenal carcinoma causing secondary amyloidosis: report of the first case in the literature. Neth J Med 2003;61:142–145.
- Overstreet K, Barone RM, Robin HS. Secondary amyloidosis and gastrointestinal stromal tumors. A case report and discussion of pathogenesis. Arch Pathol Lab Med 2003;127:470–473.
- Zhu LC, Sidhu GS, Yee HT, Cassai ND, Goldfarb DS, Wieczorek RL. AA-type amyloidosis associated with non-Hodgkin’s lymphoma: a case report. Hum Pathol 2004;35:1041–1044.
- Onishi S, Hojo N, Sakai I, Matsumoto T, Watanabe A, Miyazaki T, Ito MR, et al. Secondary amyloidosis and eosinophilia in a patient with uterine leiomyosarcoma. Jpn J Clin Oncol 2005;35:617–621.
- Pamuk GE, Demir M, Orüm H, Turgut B, Ozyilmaz F, Tekgündüz E. Secondary amyloidosis causing nephrotic syndrome in a patient with non-Hodgkin’s lymphoma: quite a rare diagnosis. Clin Lab Haematol 2006;28:259–261.
- Tajima S, Ushijima T, Matuya S, Horiuchi H. AA-type amyloidosis in association with non-Hodgkin’s lymphoma following CMV viremia: Autopsy case. Pathol Int 2010;60:222–227.
- Ramankulov A, Lein M, Johannsen M, Schrader M, Miller K, Loening SA, Jung K. Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma. Cancer Lett 2008;269:85–92.
- Cocco E, Bellone S, El-Sahwi K, Cargnelutti M, Buza N, Tavassoli FA, Schwartz PE, et al. Serum amyloid A: a novel biomarker for endometrial cancer. Cancer 2010;116:843–851.
- Le L, Chi K, Tyldesley S, Flibotte S, Diamond DL, Kuzyk MA, Sadar MD. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. Clin Chem 2005;51:695–707.
- Urieli-Shoval S, Finci-Yeheskel Z, Dishon S, Galinsky D, Linke RP, Ariel I, Levin M, et al. Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis. J Histochem Cytochem 2010;58:1015–1023.
- Suzuki M, Shinagawa N, Oizumi S, Fugo K, Nishimura M. Interleukin-6-producing undifferentiated thymic carcinoma with neuroendocrine features. Lung Cancer 2009;63:425–429.
- Baranova IN, Bocharov AV, Vishnyakova TG, Kurlander R, Chen Z, Fu D, Arias IM, et al. CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells. J Biol Chem 2010;285:8492–8506.